Abstract:Although the use of bioresorbable materials in stent production is thought to improve long-term safety compared to their durable counterparts, a recent FDA report on the 2-year follow-up of the first FDA-approved bioresorbable vascular stent showed an increased occurrence of major adverse cardiac events and thrombosis in comparison to the metallic control. In order to overcome the issues of first generation bioresorbable polymers, a series of polyethylene glycol-functionalized poly-L-lactide-co-ε-caprolactone copolymers with varying lactide-to-caprolactone content is developed using a novel one-step PEG-functionalization and copolymerization strategy. This approach represents a new facile way toward surface enhancement for cellular interaction, which is shown by screening these materials regarding their cyto- and hemocompatibility in terms of cytotoxicity, hemolysis, platelet adhesion, leucocyte activation and endothelial cell adhesion. By varying the lactide-to-caprolactone polymer composition, it is possible to gradually affect endothelial and platelet adhesion which allows fine-tuning of the biological response based on polymer chemistry. All polymers developed were non-cytotoxic, had acceptable leucocyte activation levels and presented non-hemolytic (<2% hemolysis rate) behavior except for PLCL-PEG 55:45 which presented hemolysis rate of 2.5% ± 0.5. Water contact angles were reduced in the polymers containing PEG functionalization (PLLA-PEG: 69.8° ± 2.3, PCL-PEG: 61.2° ± 7.5) versus those without (PLLA: 79.5° ± 3.2, PCL: 76.4° ± 10.2) while the materials PCL-PEG550, PLCL-PEG550 90:10 and PLCL-PEG550 70:30 demonstrated best endothelial cell adhesion. PLLA-PEG550 and PLCL-PEG550 70:30 presented as best candidates for cardiovascular implant use from a cytocompatibility perspective across the spectrum of testing completed. Altogether, these polymers are excellent innovative materials suited for an application in stent manufacture due to the ease in translation of this one-step synthesis strategy to device production and their excellent in vitro cyto- and hemocompatibility.

Biocompatibility of a New Biodegradable Poly Butylene Carbonate Electrospun Film

The Electrospinning and Its Cytocompatibility of Poly(Butylene Carbonate)

Cytocompatibility Evaluation of a Novel Series of PEG-Functionalized Lactide-Caprolactone Copolymer Biomaterials for Cardiovascular Applications

Electrospun poly(butylene carbonate) membranes for guided bone regeneration: In vitro and in vivo studies

Effect of surface treatment on the biocompatibility of microbial polyhydroxyalkanoates.

Biodegradable Poly(Butylenecarbonate) Porous Membranes For Guided Bone Regeneration: In Vitro And In Vivo Studies

Influence of Biodegradable Poly(butylene Carbonate) on Plasticized Polylactide Blown Films

Effect of lipase treatment on the biocompatibility of microbial polyhydroxyalkanoates

Synthesis, characterization and biocompatibility of novel biodegradable poly[((R)-3-hydroxybutyrate)-block-(D,L-lactide)-block-(ɛ-caprolactone)] triblock copolymers

Properties of Poly(3-Hydroxybutyrate-co-3-hydroxyhexanoate) Films Modified with Polyvinylpyrrolidone and Behavior of MC3T3-E1 Osteoblasts Cultured on the Blended Films

Effects of Surface Morphology on the Biocompatibility of Polyhydroxyalkanoates

[Biological properties study and animal experiment of polylactide/polytrimethylene carbonate blends membrane]

Haemo- and cytocompatibility of bioresorbable homo- and copolymers prepared from 1,3-trimethylene carbonate, lactides, and ε-caprolactone

Improvement of Hemocompatibility of Polycaprolactone Film Surfaces with Zwitterionic Polymer Brushes.

Biocompatibility of Poly(ε-caprolactone) Scaffold Modified by Chitosan—The Fibroblasts Proliferation in vitro

In Vitro Biocompatibility and Degradation of Terpolyester 3Hb-Co-4hb-co-3hhx, Consisting of 3-Hydroxybutyrate, 4-Hydroxybutyrate and 3-Hydroxyhexanoate.

Surface Modification of Polycaprolactone Membrane Via Aminolysis and Biomacromolecule Immobilization for Promoting Cytocompatibility of Human Endothelial Cells.

Interfacial interaction enhancement between biodegradable poly (butylene adipate-co-terephthalate) and microcrystalline cellulose based on covalent bond for improving puncture, tearing, and enzymatic degradation properties

Biocompatibility of Poly(e-caprolactone) Scaffold Modified by Chitosan— The Fibroblasts Proliferation in vitro

Biocompatibility of electro-spinning beta-tricalcium phosphate/gelatin guided tissue regeneration membrane versus polylactic acid and poly(lactide-co-glycolide) membrane

Biocompatibility studies and characterization of poly(3-hydroxybutyrate-<i>co</i>-3-hydroxyhexanoate)/polycaprolactone blends